Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence

Journal of Cardiovascular Electrophysiology

Volumn 15, Issue 8, 2004, Pages 877-884

  Osaka, Toshiyuki ^a,c   Yamazaki, Masatoshi ^a   Yokoyama, Eriko ^a   Ito, Atsushi ^a   Kodama, Itsuo ^b  

^a SHIZUOKA SAISEIKAI GENERAL HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c NONE   (Japan)

Author keywords

Atrial fibrillation; Electrical remodeling; Monophasic action potential; Sotalol

Indexed keywords

SOTALOL;

ADULT; ARTICLE; CARDIOVERSION; CHRONIC DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART PROTECTION; HEART REPOLARIZATION; HEART RIGHT ATRIUM; HEART VENTRICLE REMODELING; HUMAN; MALE; MUSCLE ACTION POTENTIAL; PRIORITY JOURNAL; REENTRY ARRHYTHMIA;

ACTION POTENTIALS; ADMINISTRATION, ORAL; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; ATRIAL FIBRILLATION; CHRONIC DISEASE; ELECTRIC COUNTERSHOCK; HEART ATRIA; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; RECURRENCE; SOTALOL; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 4444234773     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2004.03671.x     Document Type: Article

References (45)

1. Wijffels MCEF, Kirchoff CJ, Dorland R, Allessie MA: Atrial fibrillation begets atrial fibrillation: A study in chronically instrumented conscious goats. Circulation 1995;92:1954-1968.
2. Gaspo R, Bosch RF, Talajic M, Nattel S: Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. Circulation 1997;96:4027-4035.
3. Yu WC Lee SH, Tai CT, Hsieh MH, Vhen CC, Ding YA, Chang MS, Chen SA: Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man. Cardiovasc Res 1999;42:470-476.
4. Hobbs WJC, Fynn S, Todd DM, Wolfson P, Galloway M, Garratt CJ: Reversal of atrial electrical remodeling after cardioversion of persistent atrial fibrillation in humans. Circulation 2000;101:1145-1151.
5. Yue L, Feng J, Gaspo FR, Li GR, Wang Z, Nattel S: Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circulation 1997;81:512-525.
6. Van der Velden HMW, Van der Zee L, Wijffels MCEF, Van Leuven C, Dorland R, Vos MA, Jongsma HJ, Allessie MA: Atrial fibrillation in the goat induces changes in monophasic action potential and mRNA expression of ion channels involved in repolarization. J Cardiovasc Electrophysiol 2000;11:1262-1269.
7. Franz MR, Karasik PL, Li C, Moubarak J, Chavez M: Electrical remodeling on the human atrium: Similar effects in patients with chronic atrial fibrillation and atrial flutter. J Am Coll Cardiol 1997;30:1785-1792.
8. Osaka T, Itoh A, Kodama I: Action potential remodeling in the human right atrium with chronic atrial fibrillation. Pacing Clin Electrophysiol 2000;23:960-965.
9. Tieleman RG, Van Gelder IC, Crijns HJGM, De Kam PJ, Van Den Berg MP, Haaksma J, Van Der Woude HJ, Allessie MA: Early recurrences of atrial fibrillation after electrical cardioversion: A result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol 1988;31:167-173.
10. Antonaccio MJ, Singh BN: Sotalol and d-sotalol: electrophysiology, pharmacology, and role in controlling cardiac arrhythmias. In Singh BN, Wellens HJJ, Hiraoka M, eds: Electropharmacologic Control of Cardiac Arrhythmias: To Delay Conduction or to Prolong Refractoriness. Mount Kisco, NY: Futura Publishing Co., 1993:465-496.
11. Tse HF, Lau CH, Ayers GM: Long-term outcome in patients with chronic atrial fibrillation after successful internal cardioversion. Am J Cardiol 1999;83:607-609.
12. Wijffels MCEF, Dorland R, Allessie MA: Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: A comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol. J Cardiovasc Electrophysiol 1999;10:178-193.
13. Li D, Benardaeu A, Nattel S: Contrasting efficacy of dofetilide in differing experimental models of atrial fibrillation. Circulation 2000;102:104-112.
14. Van Wagoner DR, Pond AL, Lamorgese M, Rossie SS, McCarthy PM, Nerbonne JM: Atrial L-type currents and human atrial fibrillation. Circ Res 1999;85:428-436.
15. K, ACh and muscarinic receptor-medicated shortening of action potential. Circulation 2001;104:2551-2557.
16. Grammer JB, Bosch RF, Kuhlkamp V, Seipel L: Molecular remodeling of Kv4.3 potassium channels in human atrial fibrillation. J Cardiovasc Electrophysiol 2000;11:626-633.
17. + current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res 1997;80:772-781.
18. Watanabe I, Kofune T, Ohkubo K, Okuyama Y, Yamada T, Masaki R, Oshikawa N, Saito S, Ozawa Y, Kanmatsuse K. Effects of pilsicainide and nifekarant on the atrial action potential duration after successful internal cardioversion of chronic atrial fibrillation (abstr). Pacing Clin Electrophysiol 2002;25(P II):706.
19. Workman AJ, Kane KA, Russel JA, Norrie J, Raskin AC: Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodeling. Cardiovasc Res 2003;58:518-525.
20. Derkhchan K, Villemaire C, Talajic M, Nattel S: The class III antiarrhythmic drugs dofetilide and sotalol prevent AF induction by atrial premature complexes at doses that fail to terminate AF. Cardiovasc Res 2001;50:75-84.
21. Manios EG, Kanoupakis EM, Chlouverakis GI, Kaleboubas MD, Mavrakis HE, Vardas PE: Changes in atrial electrical properties following cardioversion of chronic atrial fibrillation: Relation with recurrence. Cardiovasc Res 2000;47:244-253.
22. Van Noord T, Van Gelder IC, Crijns HJGM: How to enhance acute outcome of electrical cardioversion by drug therapy: Importance of immediate reinitiation of atrial fibrillation. J Cardiovasc Electrophysiol 2003;13:822-825.
23. Tse HF, Lau CP: Electrophysiologic actions of d.l-sotalol in patients with persistent atrial fibrillation. J Am Coll Cardiol 2002;40:2150-2155.
24. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagne P, Nattel S, Thibault B: Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000;342:913-920.
25. Kochiadakis GE, Igoumenidis NE, Marketou ME, Kaleboubas MD, Simantirakis EN, Vardas PE: Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: A comparative, placebo controlled study. Heart 2000;84:251-257.
26. Shinagawa K, Takeshita-Shiroshita A, Schram G, Nattel S: Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium. Insights into the mechanism of the superior efficacy of amiodarone. Circulation 2003;107:1440-1446.
27. Morillo CA, Klein GJ, Jones DL, Guiraudon CM: Chronic rapid atrial pacing: Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 1995;91:1588-1585.
28. Ausma J, Wijffels M, Thone F, Wouters L, Allessie M, Borgers M: Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997;96:3157-3163.
29. Shi Y, Ducharme A, Li D, Gaspo R, Nattel S, Tardif JC: Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation. Cardiovasc Res 2001;52:217-225.
30. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J: Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 2002;54:361-379.
31. Li D, Shinagawa K, Pang L, Leung TK, Cardin S, Wang Z, Nattel S: Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachycardia-induced congestive heart failure. Circulation 2001;104:2608-2614.
32. Shinagawa K, Li D, Leung TK, Nattel S: Consequences of atrial tachycardia-induced remodeling depend on the preexisting atrial substrate. Circulation 2002;105:251-257.
33. Everett TH IV, Li H, Mangrum JM, McRury ID, Mitchell MA, Redick JA, Haines DE: Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation. Circulation 2000;102:1454-1460.
34. Ausma J, Van der Velden HMW, Lenders MH, Ankeren EO, Jongsma HJ, Ramaekers FC, Borger M, Allessie MA: Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat. Circulation 2003;107:2051-2058.
35. Kumagai K, Nakashima H, Urata H, Gondo N, Arakawa K, Saku K: Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol 2003;41:2197-2204.
36. Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A: Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction. Insight from the studies of left ventricular dysfunction (SOLVD) trials. Circulation 2003;107:2926-2931.
37. Goette A, Staack T, Rocken C, Arndt M, Geller JC, Huth C, Ansorge S, Klein HU, Lendeckel U: Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 2000;35:1669-1677.
38. Marid AH, Bueno MG, Rebollo JM, Marin I, Pena G, Bernal E, Rodriguez A, Cano L, Cano JM, Cabeza P, Moro C: Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: A prospective and randomized study. Circulation 2002;106:331-336.
39. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J: Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-666.
40. Pappone C, Rosanio S, Oreto G, Tocchi M, Gugliotta F, Vicedomini G, Salvati A, Dicandia C, Mazzone P, Santinelli V, Gulletta S, Chierchia S: Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomical approach for curing atrial fibrillation. Circulation 2000;102:2619-2628.
41. Wu TJ, Doshi RN, Huang HL, Blanche C, Kass RM, Trento A, Cheng W, Karagueuzian HS, Peter CT, Chen PS: Simultaneous biatrial computerized mapping during permanent atrial fibrillation in patients with organic heart disease. J Cardiovasc Electrophysiol 2002;13:571-577.
42. Li H, Hare J, Mughal K, Krum D, Biehl M, Deshpande S, Dhala A, Blanck Z, Sra J, Jazayeri M, Akhtar M: Distribution of atrial electrogram types during atrial fibrillation: Effect of rapid atrial pacing and intercaval junction ablation. J Am Coll Cardiol 1996;27:1713-1721.
43. Lai LP, Lin JL, Lien WP, Tseng YZ, Huang SK: Intravenous sotalol decreases transthoracic cardioversion energy requirement for chronic atrial fibrillation in humans: Assessment of the electrophysiological effects by biatrial basket electrodes. J Am Coll Cardiol 2000;35:1433-1441.
44. Feng J, Yue L, Wang Z, Nattel S: Ionic mechanisms of regional action potential heterogeneity in the canine right atrium. Circulation 1998;83:541-551.
45. Li D, Zhang L, Kneller J, Nattel S: Potential ionic mechanism for repolarization differences between canine right and left atrium. Circulation 2001;88:1168-1175.